Springtail | $2,500,000 | (Apr 10, 2025)
Tessell | $60,000,000 | (Apr 10, 2025)
Ottometric | $10,000,000 | (Apr 10, 2025)
Certified by Founder
Lodge
Corsair Pharma
start up
United States
- Sunnyvale, California
- 22/09/2023
- Series B
- $23,000,000
Corsair Pharma is developing transformative solutions to improve the therapeutic profile of medications and provide superior treatment options for patients. The company is focused on the development of novel prodrugs of treprostinil to treat patients with PAH using a once-daily transdermal patch.
- Industry Pharmaceutical Manufacturing
- Website https://www.corsairpharma.com/
- LinkedIn https://www.linkedin.com/company/corsairpharma/about/
Merida Biosciences | $121,000,000 | (Apr 10, 2025)
DIAMO | $4,000,000 | (Apr 10, 2025)
Rondah AI | $1,800,000 | (Apr 10, 2025)
Pax | $4,500,000 | (Apr 10, 2025)
Ryft | $7,315,294 | (Apr 10, 2025)
Remedy Scientific Inc. | $11,000,000 | (Apr 10, 2025)
Luzern Risk | $12,000,000 | (Apr 10, 2025)
Base Power Company | $200,000,000 | (Apr 10, 2025)
Adaptis | $4,000,000 | (Apr 9, 2025)